FDA Approves Hypoxico Equipment for Use in Cardiac Study
FDA says Hypoxico generators can be used in heart study to determine the effects hypoxic air has on chronic heart failure patients.
New York, NY, February 21, 2009 --(PR.com)-- The Food and Drug Administration (FDA) has approved the use of Hypoxico’s Everest Summit II Generator in a study being performed by Montefiore Medical Center.
The research study will test the effect of simulated altitude in people with chronic heart failure. In the study, cardiac patients will spend 3-4 hours per day in a Hypoxico altitude tent to determine the outcome of high altitude exposure on the heart.
“Beneficial changes occur during altitude exposure while the body is adapting to reduced oxygen content in blood,” says Dr. Maybaum, Medical Director of the Center for Advanced Cardiac Therapy at Montefiore Medical Center. “These changes are responsible for the improved exercise performance seen in athletes using this strategy.”
Participants in the study will be exposed to 10 altitude sessions over 22 days, where the amount of oxygen inside the Hypoxico tent will be adjusted slowly to mimic the amount of oxygen in the air at high altitudes. Physical examinations including blood analysis, echocardiograms, and skeletal muscle testing will be performed on the patients to determine the effects of simulated altitude exposure.
“Several changes occur in skeletal muscle in heart failure patients that leads to reduced ability to exercise,” says Dr. Maybaum. “The beneficial changes that occur in the blood, respiratory system and muscles during altitude adaptation with Hypoxico’s generators may very well be of great help to these patients.”
About Hypoxico : Hypoxico Inc. was founded in 1995 by inventor / scientist Igor (Gary) Kotliar. Hypoxico has become known among elite athletes and trainers as the company providing the best equipment for athletic training and performance. Its worldwide installations have been in use for almost a decade at some of the world’s top organizations and institutions including: the Olympic Committees for the United States, Norway, Finland, the Czech Republic, New Zealand, Brazil, German, Australian and Canadian Olympic Committees, as well as the ARCO Olympic Training Center in Barcelona and the Quebec Government Secretariat of Sport. As the pioneer in simulated altitude training technology, Hypoxico was the first company to obtain patents pertaining to the creation and application of hypoxic air and wrote and owns the rights to a number of different patents. www.hypoxico.com
About Montefiore Medical Center: Montefiore Medical Center, the University Hospital and Academic Medical Center for the Albert Einstein College of Medicine, ranks among the top one percent of all U.S. hospitals for investments in medical innovation and cutting-edge technology. Montefiore treats all major illnesses and has distinguished Centers of Excellence in cardiology and cardiac surgery, cancer care, tissue and organ transplantation, children’s health, women’s health, surgery and the surgical subspecialties. www.montefiore.org
###
The research study will test the effect of simulated altitude in people with chronic heart failure. In the study, cardiac patients will spend 3-4 hours per day in a Hypoxico altitude tent to determine the outcome of high altitude exposure on the heart.
“Beneficial changes occur during altitude exposure while the body is adapting to reduced oxygen content in blood,” says Dr. Maybaum, Medical Director of the Center for Advanced Cardiac Therapy at Montefiore Medical Center. “These changes are responsible for the improved exercise performance seen in athletes using this strategy.”
Participants in the study will be exposed to 10 altitude sessions over 22 days, where the amount of oxygen inside the Hypoxico tent will be adjusted slowly to mimic the amount of oxygen in the air at high altitudes. Physical examinations including blood analysis, echocardiograms, and skeletal muscle testing will be performed on the patients to determine the effects of simulated altitude exposure.
“Several changes occur in skeletal muscle in heart failure patients that leads to reduced ability to exercise,” says Dr. Maybaum. “The beneficial changes that occur in the blood, respiratory system and muscles during altitude adaptation with Hypoxico’s generators may very well be of great help to these patients.”
About Hypoxico : Hypoxico Inc. was founded in 1995 by inventor / scientist Igor (Gary) Kotliar. Hypoxico has become known among elite athletes and trainers as the company providing the best equipment for athletic training and performance. Its worldwide installations have been in use for almost a decade at some of the world’s top organizations and institutions including: the Olympic Committees for the United States, Norway, Finland, the Czech Republic, New Zealand, Brazil, German, Australian and Canadian Olympic Committees, as well as the ARCO Olympic Training Center in Barcelona and the Quebec Government Secretariat of Sport. As the pioneer in simulated altitude training technology, Hypoxico was the first company to obtain patents pertaining to the creation and application of hypoxic air and wrote and owns the rights to a number of different patents. www.hypoxico.com
About Montefiore Medical Center: Montefiore Medical Center, the University Hospital and Academic Medical Center for the Albert Einstein College of Medicine, ranks among the top one percent of all U.S. hospitals for investments in medical innovation and cutting-edge technology. Montefiore treats all major illnesses and has distinguished Centers of Excellence in cardiology and cardiac surgery, cancer care, tissue and organ transplantation, children’s health, women’s health, surgery and the surgical subspecialties. www.montefiore.org
###
Contact
Hypoxico, Inc.
Matthew Eckert
212-972-1009
www.hypoxico.com
Matthew Eckert
212-972-1009
www.hypoxico.com
Contact
Categories